Biocon Biologics Secures Market Entry for Denosumab Biosimilars in Europe Following Amgen Settlement..

Dailymirror.news,India,December 2, 2025: Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd., today announced a confidential settlement